Home›Companies›Biotech & Pharma›Lupvindol Biosciences

Lupvindol Biosciences LTD

Develops combination treatments for inflammation and pain in animals and people.

Updated Nov 19, 2026·Latest SEC filing Dec 23, 2024·Suggest an edit

About Lupvindol Biosciences

Lupvindol Biosciences is a private company based in Sheridan, Wyoming, incorporated in 2024 in Wyoming. It has reported $2,200,000 raised in one offering on Form D since December 2024. Its chief executive is Hunter Land.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Oct 25, 2024Dec 23, 2024$2,200,000of $12.0M target3$733KEquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Lupvindol Biosciences's Form D filed Dec 23, 2024.

Hunter Land
Hunter Land
Chief Executive Officer and director

Sources

  1. SECLupvindol Biosciences LTD filing history
  2. CompanyCanine inflammatory bowel disease announcement